P. Laflamme

Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients

L. Busque, D. Leboeuf, M. Guimond, 2017, Blood cancer journal.

ZNF768 Expression Associates with High Proliferative Clinicopathological Features in Lung Adenocarcinoma

M. Laplante, M. Orain, P. Joubert, 2021, Cancers.

Imatinib mesylate inhibits STAT5 phosphorylation in response to IL-7 and promotes T cell lymphopenia in chronic myelogenous leukemia patients

L. Busque, D. Leboeuf, M. Guimond, 2017, Blood Cancer Journal.